https://www.consultant360.com/exclusive/empagliflozin-reduces-disease-progression-mortality-ckd
0
0
12/16/22 at 5:09pm
Organization
Consultant360.com
Authors
Researchers compared the efficacy of empagliflozin use and associated outcomes with placebo in individuals with chronic kidney disease.
Create an account
or login to join the discussion